Lazard Asset Management’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Buy |
+45,398
| New | +$372K | ﹤0.01% | 1572 |
|
|
2025
Q1 | – | Sell |
-45
| Closed | – | – | 2540 |
|
|
2024
Q4 | $0 | Sell |
45
-7,585
| -99% | – | ﹤0.01% | 2495 |
|
|
2024
Q3 | $80K | Buy |
7,630
+7,511
| +6,312% | +$78.8K | ﹤0.01% | 1826 |
|
|
2024
Q2 | $0 | Sell |
119
-1,652
| -93% | – | ﹤0.01% | 2396 |
|
|
2024
Q1 | $36K | Sell |
1,771
-9,736
| -85% | -$198K | ﹤0.01% | 1786 |
|
|
2023
Q4 | $205K | Buy |
11,507
+8,917
| +344% | +$159K | ﹤0.01% | 1372 |
|
|
2023
Q3 | $41K | Buy |
2,590
+107
| +4% | +$1.69K | ﹤0.01% | 1910 |
|
|
2023
Q2 | $48K | Sell |
2,483
-3,631
| -59% | -$70.2K | ﹤0.01% | 1846 |
|
|
2023
Q1 | $114K | Sell |
6,114
-3,110
| -34% | -$58K | ﹤0.01% | 1483 |
|
|
2022
Q4 | $208K | Sell |
9,224
-1,027
| -10% | -$23.2K | ﹤0.01% | 1293 |
|
|
2022
Q3 | $270K | Buy |
10,251
+505
| +5% | +$13.3K | ﹤0.01% | 1209 |
|
|
2022
Q2 | $240K | Buy |
9,746
+3,158
| +48% | +$77.8K | ﹤0.01% | 1233 |
|
|
2022
Q1 | $218K | Buy |
6,588
+4,548
| +223% | +$150K | ﹤0.01% | 1238 |
|
|
2021
Q4 | $66K | Sell |
2,040
-1,799
| -47% | -$58.2K | ﹤0.01% | 1620 |
|
|
2021
Q3 | $160K | Buy |
3,839
+1,293
| +51% | +$53.9K | ﹤0.01% | 1324 |
|
|
2021
Q2 | $98K | Buy |
2,546
+2,494
| +4,796% | +$96K | ﹤0.01% | 1347 |
|
|
2021
Q1 | $1K | Sell |
52
-1,707
| -97% | -$32.8K | ﹤0.01% | 1827 |
|
|
2020
Q4 | $79K | Buy |
1,759
+356
| +25% | +$16K | ﹤0.01% | 1237 |
|
|
2020
Q3 | $38K | Sell |
1,403
-569
| -29% | -$15.4K | ﹤0.01% | 1270 |
|
|
2020
Q2 | $72K | Buy |
+1,972
| New | +$72K | ﹤0.01% | 1109 |
|
|
2020
Q1 | – | Sell |
-1,496
| Closed | -$61K | – | 1716 |
|
|
2019
Q4 | $61K | Buy |
+1,496
| New | +$61K | ﹤0.01% | 1018 |
|
|
2018
Q3 | – | Sell |
-18,932
| Closed | -$1.36M | – | 1098 |
|
|
2018
Q2 | $1.36M | Buy |
+18,932
| New | +$1.36M | ﹤0.01% | 703 |
|